ICD Benefits Roughly Equal For Ischemics, Non-Ischemics – JAMA Study
This article was originally published in The Gray Sheet
Executive Summary
Implantable cardioverter defibrillators are associated with roughly the same relative benefit over medical therapy in both non-ischemic and ischemic cardiomyopathy patients, according to a meta-analysis by Akshay Desai, MD, Brigham and Women's Hospital, et al.
You may also be interested in...
ICD Medicare Coverage Expansion Unwarranted, Insurance Group Contends
America's Health Insurance Plans' efforts to dissuade CMS from expanding ICD national coverage until more conclusive evidence becomes available reflects the insurance industry's insistence on evidence-based medicine to justify expensive technologies
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.